Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F
Funct Integr Genomics. 2025; 25(1):50.
PMID: 40024973
DOI: 10.1007/s10142-025-01552-x.
Dhamdhere S, Bansal A, Singh P, Kakani P, Agrawal S, Samaiya A
Cell Death Dis. 2025; 16(1):142.
PMID: 40016181
PMC: 11868403.
DOI: 10.1038/s41419-025-07461-y.
Zhang J, Aishan N, Zheng Z, Ju S, He Q, Meng Q
Epigenetics. 2025; 20(1):2473250.
PMID: 40014756
PMC: 11869774.
DOI: 10.1080/15592294.2025.2473250.
Yang Q, Wu Q, Liu H, Wu J, Ma F, Tian X
Front Pharmacol. 2025; 15():1518983.
PMID: 39830353
PMC: 11739168.
DOI: 10.3389/fphar.2024.1518983.
Aluru N, Venkataraman Y, Murray C, DePascuale V
Biol Open. 2025; 14(1.
PMID: 39760289
PMC: 11744052.
DOI: 10.1242/bio.061801.
Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.
Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Yin Z
Lab Invest. 2024; 104(12):102160.
PMID: 39426568
PMC: 11709230.
DOI: 10.1016/j.labinv.2024.102160.
Epigenomic heterogeneity as a source of tumour evolution.
Laisne M, Lupien M, Vallot C
Nat Rev Cancer. 2024; 25(1):7-26.
PMID: 39414948
DOI: 10.1038/s41568-024-00757-9.
Epithelial-Mesenchymal Plasticity and Epigenetic Heterogeneity in Cancer.
Sacco J, Gomez E
Cancers (Basel). 2024; 16(19).
PMID: 39409910
PMC: 11475326.
DOI: 10.3390/cancers16193289.
ALKBH4 functions as a hypoxia-responsive tumor suppressor and inhibits metastasis and tumorigenesis.
Chen J, Peng P, Wu H, Chen D, Hsieh C, Chang J
Cell Oncol (Dordr). 2024; .
PMID: 39400679
DOI: 10.1007/s13402-024-01004-x.
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.
de la Calle-Fabregat C, Calafell-Segura J, Gardet M, Dunsmore G, Mulder K, Ciudad L
Sci Adv. 2024; 10(38):eadq5226.
PMID: 39292770
PMC: 11409945.
DOI: 10.1126/sciadv.adq5226.
Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair response.
Rath S, Nyamsuren G, Tampe B, Yu D, Hulshoff M, Schlosser D
Clin Epigenetics. 2024; 16(1):119.
PMID: 39192299
PMC: 11350970.
DOI: 10.1186/s13148-024-01719-6.
DNA Methylation in Recurrent Glioblastomas: Increased TEM8 Expression Activates the Src/PI3K/AKT/GSK-3β/B-Catenin Pathway.
Kundu P, Jain R, Kanuri N, Arimappamagan A, Santosh V, Kondaiah P
Cancer Genomics Proteomics. 2024; 21(5):485-501.
PMID: 39191501
PMC: 11363927.
DOI: 10.21873/cgp.20466.
Tet1-mediated 5hmC regulates hippocampal neuroinflammation via wnt signaling as a novel mechanism in obstructive sleep apnoea leads to cognitive deficit.
Kong Y, Ji J, Zhan X, Yan W, Liu F, Ye P
J Neuroinflammation. 2024; 21(1):208.
PMID: 39169375
PMC: 11340128.
DOI: 10.1186/s12974-024-03189-2.
Hypoxic Memory Mediates Prolonged Tumor-Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression.
Iriondo O, Mecenas D, Li Y, Chin C, Thomas A, Moriarty A
Cancer Res. 2024; 84(19):3141-3157.
PMID: 38990731
PMC: 11444891.
DOI: 10.1158/0008-5472.CAN-23-2028.
Identification of Hypoxia-ALCAM Macrophage- Exhausted T Cell Axis in Tumor Microenvironment Remodeling for Immunotherapy Resistance.
Xun Z, Zhou H, Shen M, Liu Y, Sun C, Du Y
Adv Sci (Weinh). 2024; 11(33):e2309885.
PMID: 38956900
PMC: 11434037.
DOI: 10.1002/advs.202309885.
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.
Ci X, Chen S, Zhu R, Zarif M, Jain R, Guo W
BMC Cancer. 2024; 24(1):744.
PMID: 38890593
PMC: 11186205.
DOI: 10.1186/s12885-024-12505-1.
Mechanism of Preventing Recurrence of Stage II-III Colorectal Cancer Metastasis with Immuno-inflammatory and Hypoxic Microenvironment by a Four Ingredients Chinese Herbal Formula: A Bioinformatics and Network Pharmacology Analysis.
Shi C, Liu X, Han S, Tang Y, Zeng H, Du M
Curr Pharm Des. 2024; 30(25):2007-2026.
PMID: 38867534
DOI: 10.2174/0113816128294401240523092259.
PNPO-PLP axis senses prolonged hypoxia in macrophages by regulating lysosomal activity.
Sekine H, Takeda H, Takeda N, Kishino A, Anzawa H, Isagawa T
Nat Metab. 2024; 6(6):1108-1127.
PMID: 38822028
PMC: 11599045.
DOI: 10.1038/s42255-024-01053-4.
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.
Venken T, Miller I, Arijs I, Thomas V, Barat A, Betge J
NPJ Genom Med. 2024; 9(1):33.
PMID: 38811554
PMC: 11137102.
DOI: 10.1038/s41525-024-00415-x.
Transcriptional elongation control of hypoxic response.
Soliman S, Iwanaszko M, Zheng B, Gold S, Howard B, Das M
Proc Natl Acad Sci U S A. 2024; 121(15):e2321502121.
PMID: 38564636
PMC: 11009653.
DOI: 10.1073/pnas.2321502121.